111 related articles for article (PubMed ID: 10168639)
1. Utilization of generics: a managed care failure?
Epstein D
Manag Care; 1997 May; 6(5):85-7. PubMed ID: 10168639
[No Abstract] [Full Text] [Related]
2. Cut pharmaceutical costs, but mind the legal dangers.
Abood RR
Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246
[No Abstract] [Full Text] [Related]
3. Considerations in pharmaceutical conversion: focus on antihistamines.
Garbus SB; Moulton BW; Meltzer EO; Reich PR; Weinreb LF; Friedman JA; Orland BI
Am J Manag Care; 1997 Apr; 3(4):617-30. PubMed ID: 10169530
[TBL] [Abstract][Full Text] [Related]
4. Drug use review matters.
Mueting M
Nebr Nurse; 2007; 40(3):28. PubMed ID: 17915614
[No Abstract] [Full Text] [Related]
5. Facing the next challenge of pharmaceutical care: patient noncompliance.
Bloom DL
Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562
[TBL] [Abstract][Full Text] [Related]
6. Health plans jump on the generics bandwagon as more drugs become available.
Dis Manag Advis; 2002 Sep; 8(9):139-42, 129. PubMed ID: 12373930
[TBL] [Abstract][Full Text] [Related]
7. The effect of tiered-copay formularies on prescription drug use and spending.
Manag Care Interface; 2004 Apr; 17(4):68-9. PubMed ID: 15108762
[No Abstract] [Full Text] [Related]
8. Prescription drugs at bargain prices.
Guglielmo WJ
Newsweek; 2001 Apr; 137(17):62. PubMed ID: 11338630
[No Abstract] [Full Text] [Related]
9. Unintended consequences of a Medicaid prescription copayment policy.
Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
Med Care; 2014 May; 52(5):422-7. PubMed ID: 24686394
[TBL] [Abstract][Full Text] [Related]
10. Drug utilization review in the managed care environment.
Briesacher B; DuChane J
Med Interface; 1995 Mar; 8(3):72-4, 76-8. PubMed ID: 10141391
[TBL] [Abstract][Full Text] [Related]
11. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
Mager DE; Cox ER
Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
[TBL] [Abstract][Full Text] [Related]
12. Forecasting the future.
Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
[No Abstract] [Full Text] [Related]
13. Effective strategies for managing pharmacy benefits.
Jacobson D
Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
[TBL] [Abstract][Full Text] [Related]
14. Perspectives. Drug utilization review: apocalypse when?
Ault A
Faulkner Grays Med Health; 1992 Feb; 46(8):suppl 4 p.. PubMed ID: 10116064
[No Abstract] [Full Text] [Related]
15. Perspective. Senior drug use unique, needs management, analysts say.
Med Health; 2001 Aug; 55(30):7-8. PubMed ID: 11507947
[No Abstract] [Full Text] [Related]
16. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
17. The generics in transplantation and the rules on their use.
Masri M
Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
[TBL] [Abstract][Full Text] [Related]
18. Zero copayment for generic statins could save billions.
Manag Care; 2013 Mar; 22(3):44. PubMed ID: 23610806
[No Abstract] [Full Text] [Related]
19. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
Zain S
Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
[No Abstract] [Full Text] [Related]
20. Why do FEHBP and big unions excel at managing drug costs?
Berberabe T
Manag Care; 2003 Dec; 12(12):36-9. PubMed ID: 14723101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
